Aker BioMarine has entered into an agreement with American Industrial Partners (AIP) and Aker Capital for the sale of Aker BioMarine’s ownership position in the Feed Ingredients business, based on an enterprise valuation of USD 590 million. The acquiring party will be a newly established company owned 60% by AIP and 40% by Aker Capital.

Earlier this year, Aker BioMarine announced a strategic review of its ownership position in the Feed Ingredients business. The transaction will create significant shareholder value and is an important step in crystallizing value and enabling a focused Aker BioMarine within the human health and nutrition business.

"We are pleased to announce the sale of our ownership position in the Feed Ingredients business. This transaction is the result of a process that attracted interest from a wide range of reputable parties and not only demonstrates the value of Feed Ingredients but also underscores the value potential of Aker BioMarine as a whole. We will continue to explore how we can drive shareholder value by enabling potential partnerships and transactions for each of the remaining business units,” said Matts Johansen, CEO of Aker BioMarine.

Following the transaction, Aker BioMarine will be a focused human health and nutrition company consisting of three business units; (1) Human Health Ingredients (2) Consumer Health Ingredients and (3) Emerging Businesses. Aker BioMarine has entered into a long-term contract with Feed Ingredients for the supply of krill raw materials for its Human Health Ingredients business.

Closing of the transaction is expected during the third quarter of 2024, subject to obtaining the necessary competition clearances. Arctic, Carnegie and Rabobank acted as financial advisors to Aker BioMarine in connection with the transaction, and Schjødt as legal adviser.